QR Genetics aims to find therapeutic solutions for rare diseases by conducting personalized computational drug screening of thousands of known drugs based on the patient's genetics using automation and computational technologies. The company develops automated scalable computation modeling based on machine-learning tools for ongoing improvement of the drug screening process. It uses patients' genetic data to confirm the disease mutation with the molecular and clinical status and perform personalized drug repurposing to find potential treatments, applying technologies that combine computational and biological modeling.